VanEck Biotech ETF (BBH)
NasdaqGM: BBH
· Echtzeitkurs · USD
239.54
+17.26 (7.76%)
Zum Schluss: Aug 18, 2026, 3:57 PM
VanEck Biotech ETF (BBH) ETF Price, Holdings & Analysis
7.76% (1D)
| Geld | 210.43 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 399.88 Mio |
| NAV | 222.26 |
| Beta | 0.55 |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | 29.46 |
| Ausstehende Anteile | k.A. |
| Auflagedatum | Dec 20, 2011 |
| Brief | 210.68 |
| Volumen | 5,927 |
| Ø Vol. (20D) | 4,932 |
| Eröffnung | 224.27 |
| Vortagesschluss | 222.28 |
| Tagesspanne | 224.27 - 225.18 |
| 52-Wk Range | 160.91 - 225.25 |
| Positionen | k.A. |
| Kostenquote | 0.35% |
Über BBH
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Anlageklasse Equity
Tickersymbol BBH
Auflagedatum Dec 20, 2011
Anbieter Vaneck
Website Fonds-Homepage
Börse NasdaqGM
Top 10 Positionen 71.57% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Amgen Inc | AMGN | 15.95% |
| Gilead Sciences Inc | GILD | 12.98% |
| Vertex Pharmaceutica... | VRTX | 8.63% |
| Regeneron Pharmaceut... | REGN | 7.18% |
| Revolution Medicines... | RVMD | 5.29% |
| Iqvia Holdings Inc | IQV | 5.18% |
| Natera Inc | NTRA | 4.77% |
| Argenx Se Adr | ARGX | 4.57% |
| Illumina Inc | ILMN | 3.61% |
| Biogen Inc | BIIB | 3.41% |
Dividenden Dividendenrendite 0.40%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Dec 22, 2025 | $0.9570 | k.A. |
| Dec 23, 2024 | $1.2520 | k.A. |
| Dec 18, 2023 | $0.7130 | k.A. |
| Dec 19, 2022 | $0.7490 | k.A. |
| Dec 20, 2021 | $0.3970 | k.A. |
